News
2022 Annual General Meeting: shareholders approve all proposals
Hancock Whitney Corporation to Announce First Quarter 2022 Financial Results and Host Conference Call April 19
Hancock Whitney Corporation (Nasdaq: HWC) will announce first quarter 2022 financial results on Tuesday, April 19, 2022 after the market closes. Management will host a conference call for analysts
Humana Foundation $5.5 Million Investment Sustains Health Equity Momentum in Targeted Communities
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, continued its $5.5 million investment in six communities across the United States to improve greater
Itron and Emerson Collaborate to Offer Smart Thermostats for Demand Response Programs
Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, is collaborating with Emerson, a global technology and engineering leader, to offer reliable
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received a Phase II
Guidewire Announces Latest Group of PartnerConnect Consulting Program Specialization Recipients
Guidewire (NYSE: GWRE) announced that specializations have been awarded to two Guidewire PartnerConnect Consulting partners for the Americas (AMER) and Europe (EMEA).
The PartnerConnect Consultin
Citrix® Leads Way in Delivering Secure Hybrid Work
The world is rapidly moving to hybrid work. And Citrix Systems, Inc. (NASDAQ: CTXS) is a recognized frontrunner in delivering all the technologies required to enable it.
“As companies transition
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced dosing of the first patient in the Phase 1/2 STEADFAST clinical study evaluating TX200, a wholly-owned
Tokens.com Launches Canada SailGP Team Metaverse Headquarters
Tokens.com Corp. (NEO Exchange Canada: COIN) (Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or “the Company”), a publicly-traded company that invests in Web3 crypto assets and
Xebec Presents Three-Year Strategic Plan to Power Its Growth in Sustainable Gases
Xebec Adsorption Inc. (TSX: XBC) (“Xebec”), a global provider of sustainable gas technologies, is pleased to announce today its three-year strategic plan to power its growth in sustainable gases
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Pfizer Announces Positive Top-line Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis, Underscoring Best-in-Class Potential
Pfizer Inc. (NYSE: PFE) today announced positive top-line results from a second Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor
Leading Northern Ireland Convenience Retailer The Henderson Group Selects GLORY CASHINFINITYTM Solutions As Key Enabler for Store Transformation Programme
Glory (TYO: 6457), a global leader in retail cash automation solutions today announced that major Northern Ireland retailer The Henderson Group, has signed a significant new order with the company
Recordati Rare Diseases Announce Publication in the Journal of Clinical Endocrinology & Metabolism of the Phase III LINC 4 Study Confirming the Efficacy and Safety of Isturisa® (Osilodrostat) in Patients With Cushing’s Disease
Recordati Rare Diseases announce today the publication of positive results from the Phase III LINC 4 study of Isturisa in The Journal of Clinical Endocrinology & Metabolism.1 These data reinforce
SES to Enable European Maritime Safety Agency RPAS Operations via Satellite
The latest contract awarded by the European Maritime Safety Agency (EMSA) will see the agency continue to use SES’s high-performance satellite connectivity services for Remotely Piloted Aircraft
Valbiotis Announces the Positive Results of Its Clinical Study on the Bioavailability and Mode of Action of TOTUM•070, Against Hypercholesterolemia
Regulatory News:
Valbiotis (FR0013254851 - ALVAL, PEA-SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic and
DGAP-News: ElringKlinger concludes 2021 financial year with strong growth in revenue and earnings
DGAP-News: CANCOM: CANCOM closes financial year 2021 with record EBIT growth of 31 percent and proposes dividend increase to EUR 1.00
DGAP-News: Pfeiffer Vacuum Technology AG: Pfeiffer Vacuum reports record sales and increased operating profit for fiscal year 2021 - strong demand entering 2022
DGAP-News: Wacker Neuson Group with clear rise in revenue and profitability
Intuit Responds to Complaint from U.S. Federal Trade Commission
Intuit Inc. (Nasdaq: INTU), the global technology platform that makes TurboTax, QuickBooks, Mint, Credit Karma and Mailchimp, announced that it will vigorously challenge a complaint filed today in